Indication
Blood Disorder
1 clinical trial
1 product
Clinical trial
A Phase 1/2 Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients With Residual FVIII Levels ≤ 1 IU/dL and Pre-existing Antibodies Against AAV5Status: Active (not recruiting), Estimated PCD: 2024-11-01
Product
Valoctocogene Roxaparvovec